Dyne Therapeutics Inc (DYN) financials · $1.19B cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Dyne Therapeutics Inc (DYN) $1.19B cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$468.2M | -$343.9M |
| Net Income | -$446.2M | -$317.4M |
| EPS (Diluted) | -$3.47 | -$3.37 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $1.19B | $691.2M |
| Current Assets | $1.13B | $659.3M |
| Cash & Equivalents | $893.4M | $435.4M |
| PP&E | $24.0M | $5.40M |
| Total Liabilities | $214.8M | $61.4M |
| Current Liabilities | $50.6M | $42.3M |
| Long-term Debt | $148.9M | N/A |
| Total Debt | $148.9M† | N/A |
| Shareholders' Equity | $972.1M | $629.8M |
| Retained Earnings | -$1.40B | -$949.9M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$403.2M | -$292.4M |
| CapEx | $1.92M | $2.38M |
| Investing Cash Flow | -$28.8M | -$204.1M |
| Financing Cash Flow | $890.3M | $809.9M |
| Net Change in Cash | $458.3M | $313.4M |
| Free Cash Flow | -$405.1M | -$294.7M |
FAQ
What is DYN P/E and revenue?
Dyne Therapeutics Inc (DYN) $1.19B cap.
What is DYN revenue?
DYN income-statement cache has no revenue figure yet.
Is DYN profitable?
Dyne Therapeutics Inc last cached net income is -$446.2M (FY2025).
What are DYN total assets?
Dyne Therapeutics Inc last cached total assets are $1.19B (FY2025).
What is DYN free cash flow?
Dyne Therapeutics Inc last cached free cash flow is -$405.1M (FY2025).
Not investment advice. Cached statements, not a live tape.